Cited by 33

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

2025 Seoul Consensus on Clinical Practice Guidelines for Irritable Bowel Syndrome

Choi, Yonghoon, Youn, Young Hoon, Kang, Seung Joo, Shin, Jeong Eun, Cho, Young Sin, Jung, Yoon Suk, Shin, Seung Yong, Huh, Cheal Wung, Lee, Yoo Jin, Koo, Hoon Sup, Nam, Kwangwoo, Lee, Hong Sub, Kim, Dong Hyun, Park, Ye Hyun, Kim, Min Cheol, Song, Hyo Yeop, Yoon, Sung-Hoon, Lee, Sang Yeol, Choi, Miyoung, Park, Moo-In, Sung, In-Kyung, the Korean Society of Neurogastroenterology and Motility·2025·Journal of Neurogastroenterology and Motility

DOI 10.5056/jnm25007

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.5056/jnm25007

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better?
Ma, L.-L., Wang, Y.-Y., Yang, Z.-H., Huang, D., Weng, H., & Zeng, X.-T. (2020) · Military Medical Research · doi:10.1186/s40779-020-00238-8 · Cited by 1,648
Neurotransmitter modulation by the gut microbiota
Strandwitz, P. (2018) · Brain Research · doi:10.1016/j.brainres.2018.03.015 · Cited by 1,527
Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation
Pimentel, M., Lembo, A., Chey, W. D., Zakko, S., Ringel, Y., Yu, J., Mareya, S. M., Shaw, A. L., Bortey, E., & Forbes, W. P. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1004409 · Cited by 1,036
ACG Clinical Guideline: Management of Irritable Bowel Syndrome
Lacy, B. E., Pimentel, M., Brenner, D. M., Chey, W. D., Keefer, L. A., Long, M. D., & Moshiree, B. (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001036 · Cited by 893 · cited 8×
“17 IBS can arise within months following bacterial, viral, and parasitic GI infections, as the reported risk is 3.5-4.2 times higher in exposed individuals compared to non-exposed individuals, 80-82 although the prevalence of post-infectious IBS varies.”
Influential
What is new in Rome IV
Schmulson, M. J., & Drossman, D. A. (2017) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm16214 · Cited by 788
Gut Microbiota in Patients With Irritable Bowel Syndrome—A Systematic Review
Pittayanon, R., Lau, J. T., Yuan, Y., Leontiadis, G. I., Tse, F., Surette, M., & Moayyedi, P. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.03.049 · Cited by 719
Self-Reported Food-Related Gastrointestinal Symptoms in IBS Are Common and Associated With More Severe Symptoms and Reduced Quality of Life
Böhn, L., Störsrud, S., Törnblom, H., Bengtsson, U., & Simrén, M. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.105 · Cited by 655
Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders 1 1This study was registered with ClinicalTrials.gov (trial registry no. NCT00006157).
Drossman, D. A., Toner, B. B., Whitehead, W. E., Diamant, N. E., Dalton, C. B., Duncan, S., Emmott, S., Proffitt, V., Akman, D., Frusciante, K., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00669-3 · Cited by 614
British Society of Gastroenterology guidelines on the management of irritable bowel syndrome
Vasant, D. H., Paine, P. A., Black, C. J., Houghton, L. A., Everitt, H. A., Corsetti, M., Agrawal, A., Aziz, I., Farmer, A. D., Eugenicos, M. P., et al. (2021) · Gut · doi:10.1136/gutjnl-2021-324598 · Cited by 592 · cited 8×
“Statement 16.”
Influential
A placebo-controlled trial of prucalopride for severe chronic constipation
Camilleri, M., Kerstens, R., Rykx, A., & Vandeplassche, L. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800670 · Cited by 576
CONTROLLED TRIAL OF HYPNOTHERAPY IN THE TREATMENT OF SEVERE REFRACTORY IRRITABLE-BOWEL SYNDROME
Whorwell, P. J., Prior, A., & Faragher, E. B. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92793-4 · Cited by 537
Biopsychosocial Aspects of Functional Gastrointestinal Disorders: How Central and Environmental Processes Contribute to the Development and Expression of Functional Gastrointestinal Disorders
Van Oudenhove, L., Levy, R. L., Crowell, M. D., Drossman, D. A., Halpert, A. D., Keefer, L., Lackner, J. M., Murphy, T. B., & Naliboff, B. D. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.027 · Cited by 512
Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: A Systematic Review and Meta-analysis
Klem, F., Wadhwa, A., Prokop, L. J., Sundt, W. J., Farrugia, G., Camilleri, M., Singh, S., & Grover, M. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.12.039 · Cited by 474
Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis
Ford, A. C., Lacy, B. E., Harris, L. A., Quigley, E. M. M., & Moayyedi, P. (2019) · American Journal of Gastroenterology · doi:10.1038/s41395-018-0222-5 · Cited by 467 · cited 2×
“200,243 Psychological therapies appeared to be effective treatments for IBS with an NNT of 4 in both analyses, 200,243 with CBT-based interventions and GDH having the largest evidence base.”
Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome
THABANE, M., KOTTACHCHI, D. T., & MARSHALL, J. K. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03399.x · Cited by 466
Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction.
Whitehead, W. E., Crowell, M. D., Robinson, J. C., Heller, B. R., & Schuster, M. M. (1992) · Gut · doi:10.1136/gut.33.6.825 · Cited by 432 · cited 3×
“…the effectiveness of lubiprostone, we analyzed data from RCTs, specifically those conducted by Johanson et al 220 and Chang et al. 222 These studies examined the daily doses of 16, 32, and 64 μ g of lubiprostone and compared their effects on abdominal pain and bloating improvement against placebo.”
A diet low in FODMAPs reduces symptoms in patients with irritable bowel syndrome and a probiotic restores bifidobacterium species: a randomized controlled trial
Staudacher, H. M., Lomer, M. C. E., Farquharson, F. M., Louis, P., Fava, F., Franciosi, E., Scholz, M., Tuohy, K. M., Lindsay, J. O., Irving, P. M., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.06.010 · Cited by 430
Clinical trial: lubiprostone in patients with constipation‐associated irritable bowel syndrome – results of two randomized, placebo‐controlled studies
DROSSMAN, D. A., CHEY, W. D., JOHANSON, J. F., FASS, R., SCOTT, C., PANAS, R., & UENO, R. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03881.x · Cited by 399 · cited 1×
“In Drossman’s study, 221 which analyzed 2 RCTs (Study 0431 and Study 0432), a significant response rate was observed compared to placebo.”
Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome
Ruepert, L., Quartero, A. O., de Wit, N. J., van der Heijden, G. J., Rubin, G., & Muris, J. W. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003460.pub3 · Cited by 389
American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome
Ford, A. C., Moayyedi, P., Chey, W. D., Harris, L. A., Lacy, B. E., Saito, Y. A., & Quigley, E. M. M. (2018) · American Journal of Gastroenterology · doi:10.1038/s41395-018-0084-x · Cited by 388
A systematic review of the safety of probiotics
Didari, T., Solki, S., Mozaffari, S., Nikfar, S., & Abdollahi, M. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.872627 · Cited by 367
Altered 5-Hydroxytryptamine Signaling in Patients With Constipation- and Diarrhea-Predominant Irritable Bowel Syndrome
Atkinson, W., Lockhart, S., Whorwell, P. J., Keevil, B., & Houghton, L. A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.09.031 · Cited by 355 · cited 1×
“143,144 In the intestine, 5-HT 3 receptors play an important role in regulating intestinal motility, secretion, and visceral sensitivity.”
Clinical trial: The efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation: A 12-week, randomized, double-blind, placebo-controlled study
QUIGLEY, E. M. M., VANDEPLASSCHE, L., KERSTENS, R., & AUSMA, J. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03884.x · Cited by 344
Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome
Lembo, A., Pimentel, M., Rao, S. S., Schoenfeld, P., Cash, B., Weinstock, L. B., Paterson, C., Bortey, E., & Forbes, W. P. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.08.003 · Cited by 310
Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis
Black, C. J., Thakur, E. R., Houghton, L. A., Quigley, E. M. M., Moayyedi, P., & Ford, A. C. (2020) · Gut · doi:10.1136/gutjnl-2020-321191 · Cited by 299 · cited 2×
“200,243 Psychological therapies appeared to be effective treatments for IBS with an NNT of 4 in both analyses, 200,243 with CBT-based interventions and GDH having the largest evidence base.”
Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers
Camilleri, M., Bharucha, A. E., Ueno, R., Burton, D., Thomforde, G. M., Baxter, K., McKinzie, S., & Zinsmeister, A. R. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00264.2005 · Cited by 253
Many Patients With Irritable Bowel Syndrome Have Atypical Food Allergies Not Associated With Immunoglobulin E
Fritscher-Ravens, A., Pflaum, T., Mösinger, M., Ruchay, Z., Röcken, C., Milla, P. J., Das, M., Böttner, M., Wedel, T., & Schuppan, D. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.03.046 · Cited by 248
A cognitive-behavioral treatment for irritable bowel syndrome using interoceptive exposure to visceral sensations
Craske, M. G., Wolitzky-Taylor, K. B., Labus, J., Wu, S., Frese, M., Mayer, E. A., & Naliboff, B. D. (2011) · Behaviour Research and Therapy · doi:10.1016/j.brat.2011.04.001 · Cited by 243
Linaclotide Improves Abdominal Pain and Bowel Habits in a Phase IIb Study of Patients With Irritable Bowel Syndrome With Constipation
Johnston, J. M., Kurtz, C. B., MacDougall, J. E., Lavins, B. J., Currie, M. G., Fitch, D. A., O'Dea, C., Baird, M., & Lembo, A. J. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.08.041 · Cited by 229
Assessing telephone-delivered cognitive–behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): a multicentre randomised trial
Everitt, H. A., Landau, S., O’Reilly, G., Sibelli, A., Hughes, S., Windgassen, S., Holland, R., Little, P., McCrone, P., Bishop, F., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317805 · Cited by 198
Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome
Lackner, J. M., Jaccard, J., Keefer, L., Brenner, D. M., Firth, R. S., Gudleski, G. D., Hamilton, F. A., Katz, L. A., Krasner, S. S., Ma, C.-X., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.03.063 · Cited by 191
Colonic Transit Time and IBS Symptoms: What's the Link?
Törnblom, H., Van Oudenhove, L., Sadik, R., Abrahamsson, H., Tack, J., & Simrén, M. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.5 · Cited by 185
Randomized Clinical Trial: Macrogol/PEG 3350 Plus Electrolytes for Treatment of Patients With Constipation Associated With Irritable Bowel Syndrome
Chapman, R. W., Stanghellini, V, Geraint, M., & Halphen, M. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.197 · Cited by 180
The Yield of Colonoscopy in Patients With Non-Constipated Irritable Bowel Syndrome: Results From a Prospective, Controlled US Trial
Chey, W. D., Nojkov, B., Rubenstein, J. H., Dobhan, R. R., Greenson, J. K., & Cash, B. D. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.55 · Cited by 175
Efficacy of soluble fibre, antispasmodic drugs, and gut–brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis
Black, C. J., Yuan, Y., Selinger, C. P., Camilleri, M., Quigley, E. M. M., Moayyedi, P., & Ford, A. C. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30324-3 · Cited by 171
Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis
Black, C. J., Burr, N. E., Quigley, E. M. M., Moayyedi, P., Houghton, L. A., & Ford, A. C. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.08.021 · Cited by 166
Reappraisal of probiotics’ safety in human
Sotoudegan, F., Daniali, M., Hassani, S., Nikfar, S., & Abdollahi, M. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.04.032 · Cited by 154
Irritable bowel syndrome in adults in primary care: summary of updated NICE guidance
Hookway, C., Buckner, S., Crosland, P., & Longson, D. (2015) · BMJ · doi:10.1136/bmj.h701 · Cited by 148
Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs
Harvie, R. M., Chisholm, A. W., Bisanz, J. E., Burton, J. P., Herbison, P., Schultz, K., & Schultz, M. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i25.4632 · Cited by 143
Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis
Goodoory, V. C., Khasawneh, M., Black, C. J., Quigley, E. M. M., Moayyedi, P., & Ford, A. C. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.07.018 · Cited by 128 · cited 2×
“16,17,188,189 Probiotics are believed to alleviate IBS symptoms primarily through the modulation of the gut microbiota, making them a promising option for patients with bloating, abdominal pain, and overall symptom burden.”
Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial
Flik, C. E., Laan, W., Zuithoff, N. P. A., van Rood, Y. R., Smout, A. J. P. M., Weusten, B. L. A. M., Whorwell, P. J., & de Wit, N. J. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(18)30310-8 · Cited by 126
A controlled evaluation of group cognitive therapy in the treatment of irritable bowel syndrome
Blanchard, E. B., Lackner, J. M., Sanders, K., Krasner, S., Keefer, L., Payne, A., Gudleski, G. D., Katz, L., Rowell, D., Sykes, M., et al. (2007) · Behaviour Research and Therapy · doi:10.1016/j.brat.2006.07.003 · Cited by 121
Efficacy and tolerability of guanylate cyclase-C agonists for irritable bowel syndrome with constipation and chronic idiopathic constipation: A systematic review and meta-analysis
Shah, E. D., Kim, H. M., & Schoenfeld, P. (2018) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.495 · Cited by 119
The Effects of Exercise upon Symptoms and Quality of Life in Patients Diagnosed with Irritable Bowel Syndrome: A Randomised Controlled Trial
Daley, A., Grimmett, C., Roberts, L., Wilson, S., Fatek, M., Roalfe, A., & Singh, S. (2008) · International Journal of Sports Medicine · doi:10.1055/s-2008-1038600 · Cited by 118
Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial
Everitt, H. A., Landau, S., O'Reilly, G., Sibelli, A., Hughes, S., Windgassen, S., Holland, R., Little, P., McCrone, P., Bishop, F. L., et al. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30243-2 · Cited by 116
Prucalopride in the treatment of chronic constipation in patients from the Asia-pacific region: A randomized, double-blind, placebo-controlled study
Ke, M., Zou, D., Yuan, Y., Li, Y., Lin, L., Hao, J., Hou, X., & Kim, H. J. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01983.x · Cited by 107
Bloating and Distension in Irritable Bowel Syndrome: The Role of Gastrointestinal Transit
Agrawal, A., Houghton, L. A., Reilly, B., Morris, J., & Whorwell, P. J. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.251 · Cited by 104
Is a negative colonoscopy associated with reassurance or improved health-related quality of life in irritable bowel syndrome?
Spiegel, B. M. R., Gralnek, I. M., Bolus, R., Chang, L., Dulai, G. S., Naliboff, B., & Mayer, E. A. (2005) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2005.08.016 · Cited by 87
Evidence for Pelvic Floor Dyssynergia in Patients With Irritable Bowel Syndrome
Suttor, V. P., Prott, G. M., Hansen, R. D., Kellow, J. E., & Malcolm, A. (2010) · Diseases of the Colon & Rectum · doi:10.1007/dcr.0b013e3181c188e8 · Cited by 66
Durability and Decay of Treatment Benefit of Cognitive Behavioral Therapy for Irritable Bowel Syndrome: 12-Month Follow-Up
Lackner, J. M., Jaccard, J., Radziwon, C. D., Firth, R. S., Gudleski, G. D., Hamilton, F., Katz, L. A., Keefer, L., Krasner, S. S., Ma, C.-X., et al. (2019) · American Journal of Gastroenterology · doi:10.1038/s41395-018-0396-x · Cited by 61 · cited 1×
“The largest RCTs are of CBT, 27,234,236-239 and RCTs for GDH trials are fewer but show similar outcomes to CBT. 240-242 Recently, there were a couple of network meta-analyses conducted to analyze the effect of gut-directed psychotherapy.”
The impact of abuse and mood on bowel symptoms and health‐related quality of life in irritable bowel syndrome (IBS)
Kanuri, N., Cassell, B., Bruce, S. E., White, K. S., Gott, B. M., Gyawali, C. P., & Sayuk, G. S. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12848 · Cited by 59
Relative Efficacy of Tegaserod in a Systematic Review and Network Meta-analysis of Licensed Therapies for Irritable Bowel Syndrome With Constipation
Black, C. J., Burr, N. E., & Ford, A. C. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.07.007 · Cited by 58
Anticholinergic side effects of tricyclic antidepressants and their management
Remick, R. A. (1988) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(88)90039-5 · Cited by 56 · cited 1×
“212,213 These risks necessitate caution during treatment.”
Efficacy of linaclotide in reducing abdominal symptoms of bloating, discomfort, and pain: A phase 3B trial using a novel abdominal scoring system
Chang, L., Lacy, B. E., Moshiree, B., Kassebaum, A., Abel, J. L., Hanlon, J., Bartolini, W., Boinpally, R., Bochenek, W., Fox, S. M., et al. (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001334 · Cited by 56
Imipramine versus placebo for multiple functional somatic syndromes (STreSS-3): a double-blind, randomised study
Agger, J. L., Schröder, A., Gormsen, L. K., Jensen, J. S., Jensen, T. S., & Fink, P. K. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30126-8 · Cited by 52
Clinical practice guidelines for irritable bowel syndrome in Korea, 2017 revised edition
Song, K. H., Jung, H.-K., Kim, H. J., Koo, H. S., Kwon, Y. H., Shin, H. D., Lim, H. C., Shin, J. E., Kim, S. E., Cho, D. H., et al. (2018) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm17145 · Cited by 47 · cited 1×
“10,16,17 The diagnosis of IBS begins with careful history-taking.”
Bimodal Release Ondansetron Improves Stool Consistency and Symptomatology in Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Trial
Plasse, T. F., Barton, G., Davidson, E., Abramson, D., Kalfus, I., Fathi, R., Raday, G., & Harris, M. S. (2020) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000727 · Cited by 40
A Randomized Parallel-group Study of Digital Gut-directed Hypnotherapy vs Muscle Relaxation for Irritable Bowel Syndrome
Berry, S. K., Berry, R., Recker, D., Botbyl, J., Pun, L., & Chey, W. D. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.06.015 · Cited by 32 · cited 1×
“The largest RCTs are of CBT, 27,234,236-239 and RCTs for GDH trials are fewer but show similar outcomes to CBT. 240-242 Recently, there were a couple of network meta-analyses conducted to analyze the effect of gut-directed psychotherapy.”

Research works printed but not linked: 184

10.1053/j.gastro.2016.02.031 · DOI · Paper page
10.1016/S2468-1253(16)30023-1 · DOI · Paper page
10.1111/apt.12938 · DOI · Paper page
10.3748/wjg.v29.i26.4120 · DOI · Paper page
10.1056/NEJMra1607547 · DOI · Paper page
Park HJ. Evidence based guideline for diagnosis and treatment: therapeutic guideline for irritable bowel syndrome. Kor J Neurogastroenterol Motil 2005;11:36-43.
10.4166/kjg.2010.55.5.308 · DOI
10.4166/kjg.2011.57.2.82 · DOI
10.1111/j.1440-172X.2012.02017.x · DOI
10.1016/j.jclinepi.2012.03.013 · DOI · Paper page
10.1007/s00535-020-01746-z · DOI · Paper page
10.1053/j.gastro.2022.04.017 · DOI · Paper page
10.1136/gut.52.11.1616 · DOI
10.1007/s003840000248 · DOI
10.1111/1751-2980.12098 · DOI
10.1192/bjp.163.3.315 · DOI
10.1038/ajg.2013.19 · DOI · Paper page
10.1016/S0140-6736(89)90013-5 · DOI · Paper page
10.1136/gutjnl-2012-302514d.63 · DOI
10.1159/000338301 · DOI
10.1016/j.jpsychores.2017.12.002 · DOI
10.15403/jgld-3952 · DOI
10.1053/j.gastro.2018.07.011 · DOI
10.1620/tjem.151.373 · DOI
10.1038/nrdp.2016.14 · DOI
10.1136/gutjnl-2012-304066 · DOI · Paper page
10.1053/j.gastro.2015.10.047 · DOI · Paper page
10.1111/j.1365-2982.2011.01732.x · DOI
10.1046/j.1365-2036.2002.01287.x · DOI
10.1136/gut.42.6.845 · DOI
10.1038/s41598-017-09635-x · DOI
10.1053/j.gastro.2016.02.032 · DOI
10.1136/gutjnl-2011-300474 · DOI · Paper page
10.3748/wjg.v20.i39.14126 · DOI · Paper page
10.1016/j.jpsychores.2021.110694 · DOI
10.1097/PSY.0000000000001141 · DOI
10.1053/gast.2001.27995 · DOI
10.1136/gut.2003.021857 · DOI
10.1007/s00535-012-0573-4 · DOI
10.3109/00365521.2015.1007079 · DOI
10.1111/j.1365-2036.2006.02956.x · DOI · Paper page
Black TP, Manolakis CS, Di Palma JA. "Red flag" evaluation yield in irritable bowel syndrome. J Gastrointestin Liver Dis 2012;21:153-156.
10.1002/ibd.20059 · DOI
10.1111/apt.13573 · DOI
10.1002/ueg2.12259 · DOI · Paper page
10.1002/jcla.23913 · DOI
10.5056/jnm20140 · DOI
10.3748/wjg.v30.i9.1154 · DOI
10.1016/j.gtc.2005.02.007 · DOI
10.1111/j.1572-0241.2002.07027.x · DOI
10.1371/journal.pone.0106478 · DOI
10.1186/1471-230X-12-55 · DOI
10.1053/gast.2001.20912 · DOI
10.1136/gut.2007.146357 · DOI · Paper page
10.1038/ajg.2015.6 · DOI · Paper page
10.1053/j.gastro.2019.06.014 · DOI · Paper page
10.1111/j.1572-0241.2007.01556.x · DOI · Paper page
10.1053/gast.2002.34755 · DOI · Paper page
10.1186/1471-230X-14-121 · DOI
10.1111/j.1572-0241.2003.07458.x · DOI · Paper page
10.1111/j.1365-2036.2010.04306.x · DOI
10.1136/bmj.c3369 · DOI
10.1111/apt.13283 · DOI
10.1002/ibd.20275 · DOI · Paper page
10.1111/apt.13006 · DOI
10.1038/ajg.2012.102 · DOI
10.1186/1471-230X-9-27 · DOI
10.1053/j.gastro.2019.12.021 · DOI · Paper page
10.1016/S1473-3099(15)00349-7 · DOI
10.1111/j.1365-2982.2010.01503.x · DOI
10.1007/s00384-010-0950-5 · DOI
10.5056/jnm17139 · DOI
10.1053/j.gastro.2016.02.009 · DOI · Paper page
10.1097/MCG.0b013e31820c6001 · DOI
10.1038/ctg.2015.30 · DOI
10.1053/j.gastro.2005.11.014 · DOI · Paper page
10.1016/j.cgh.2008.02.060 · DOI
10.1053/j.gastro.2009.07.057 · DOI · Paper page
10.1136/gut.2007.119446 · DOI · Paper page
10.1111/nmo.14004 · DOI
10.1038/ajg.2010.47 · DOI
10.1002/ueg2.12270 · DOI
10.1016/j.cgh.2012.12.038 · DOI
10.5217/ir.2023.00199 · DOI
10.1177/2050640613499567 · DOI
10.1038/ajg.2012.49 · DOI
10.1053/j.gastro.2013.09.046 · DOI · Paper page
10.3945/jn.112.159285 · DOI · Paper page
10.1038/ajg.2016.434 · DOI
10.1053/j.gastro.2015.07.054 · DOI · Paper page
10.1136/gutjnl-2015-311339 · DOI · Paper page
10.3748/wjg.v20.i43.16215 · DOI
10.1111/jgh.14051 · DOI
10.3390/nu11122856 · DOI
10.14309/ajg.0000000000000641 · DOI
10.1111/jgh.15410 · DOI
10.1093/ajcn/nqab005 · DOI
10.1016/j.cgh.2022.02.045 · DOI
10.1093/ajcn/nqac176 · DOI
Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep 1985;100:126-131.
10.5009/gnl13437 · DOI
10.1111/j.1572-0241.2006.00873.x · DOI
10.1080/19490976.2018.1562268 · DOI
10.1002/14651858.CD011497.pub2 · DOI
10.1007/s10880-009-9182-7 · DOI
10.1080/13548506.2015.1051557 · DOI · Paper page
10.3389/fnut.2021.637010 · DOI · Paper page
10.1038/ajg.2014.195 · DOI
10.1038/ajg.2013.63 · DOI
10.1111/j.1463-1318.2009.01990.x · DOI · Paper page
10.1177/1756283X09104794 · DOI
Khalif IL, Quigley EM, Makarchuk PA, Golovenko OV, Podmarenkova LF, Dzhanayev YA. Interactions between symptoms and motor and visceral sensory responses of irritable bowel syndrome patients to spasmolytics (antispasmodics). J Gastrointestin Liver Dis 2009;18:17-22.
10.3109/00365528709091003 · DOI
10.3109/00365528709091004 · DOI
10.1111/j.1572-0241.2000.03177.x · DOI
10.1146/annurev.med.60.042307.110802 · DOI · Paper page
10.1111/j.1365-2036.2006.02858.x · DOI
10.1371/journal.pone.0172846 · DOI
10.1016/j.cgh.2007.12.015 · DOI
10.20524/aog.2021.0619 · DOI
10.1186/s12876-017-0734-2 · DOI
10.1136/gutjnl-2018-318160 · DOI · Paper page
10.1007/s00535-016-1165-5 · DOI
10.1016/j.cgh.2013.11.024 · DOI
10.1111/nmo.13023 · DOI
10.1159/000150632 · DOI
10.1080/00365520802240255 · DOI
10.1186/s13030-017-0092-x · DOI
10.1111/j.1572-0241.2001.04128.x · DOI
10.1016/S1542-3565(04)00284-8 · DOI
10.1111/j.1572-0241.2007.01282.x · DOI
10.1046/j.1365-2036.2000.00684.x · DOI
10.1046/j.1365-2036.1999.00610.x · DOI
10.1016/S0140-6736(00)02033-X · DOI
10.1001/archinte.161.14.1733 · DOI · Paper page
10.1111/j.1572-0241.2005.40365.x · DOI
10.1111/j.1572-0241.2004.30509.x · DOI
10.1111/j.1365-2036.2004.02180.x · DOI
10.1111/j.1440-1746.2006.04543.x · DOI
10.1111/j.1365-2036.2012.05011.x · DOI · Paper page
10.14309/ajg.0000000000001313 · DOI
10.14309/ajg.0000000000002249 · DOI
10.1053/j.gastro.2022.04.016 · DOI · Paper page
10.1111/j.1365-2982.2007.01059.x · DOI
10.1053/gast.2001.21166 · DOI
10.1136/gut.2008.162404 · DOI · Paper page
10.5056/jnm14029 · DOI
10.1111/apt.12571 · DOI
10.1111/j.1365-2982.2010.01637.x · DOI
10.1007/s10620-022-07588-4 · DOI
10.7326/0003-4819-145-8-200610170-00004 · DOI · Paper page
10.3390/nu11092048 · DOI
10.1017/S002966511000011X · DOI
10.1002/mnfr.201600240 · DOI · Paper page
10.2174/1573401311309020004 · DOI
10.2174/187221309787158461 · DOI
10.3390/nu12041107 · DOI
10.1097/01.mcg.0000128929.37156.a7 · DOI
Youssef L, Francis M, Mladenovic A, et al. Probiotics: in sickness and in health. IJRSFP (USA) 2018;9:29192-29203.
10.1111/nmo.14289 · DOI
10.1016/S0140-6736(23)01523-4 · DOI
Li WD, Jia L, Jiang SM, Ping L, Xu M. The therapeutic effect of low-dose amitriptyline on patients with refractory diarrhea-predominant irritable bowel syndrome and its 1-year follow-up study. Int J Clin Exp Med 2019;12:891-898.
10.1007/s10620-007-9830-4 · DOI
10.1111/j.1365-2036.2008.03633.x · DOI
10.3748/wjg.15.3636 · DOI
10.1016/S0033-3182(78)70930-8 · DOI
10.1016/j.amjmed.2009.09.010 · DOI
10.3949/ccjm.86a.19005 · DOI
10.1146/annurev.me.35.020184.002443 · DOI
10.1016/j.clinthera.2010.07.002 · DOI
10.1016/j.coph.2008.07.012 · DOI
10.1111/j.1365-2982.2012.01945.x · DOI
10.1053/j.gastro.2022.04.017 · DOI · Paper page
10.1111/j.1365-2036.2008.03629.x · DOI
10.1111/apt.13807 · DOI
10.1111/j.1365-2036.2011.04983.x · DOI
10.1038/ajg.2012.254 · DOI · Paper page
10.1038/ajg.2012.255 · DOI
10.1111/jgh.14086 · DOI
10.14309/ajg.0000000000001038 · DOI
10.14309/ajg.0000000000001247 · DOI
10.1016/j.cpr.2016.11.001 · DOI
10.3310/hta23170 · DOI
10.7759/cureus.54138 · DOI

Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines
Pastras, P., Aggeletopoulou, I., Bali, M., & Triantos, C. (2026) · Nutrients · doi:10.3390/nu18020183 · Cited by 1

See all 33

Authors: Choi, Y., Youn, Y. H., Kang, S. J., Shin, J. E., Cho, Y. S., Jung, Y. S., Shin, S. Y., Huh, C. W., Lee, Y. J., Koo, H. S., Nam, K., Lee, H. S., Kim, D. H., Park, Y. H., Kim, M. C., Song, H. Y., Yoon, S.-H., Lee, S. Y., Choi, M., Park, M.-I., Sung, I.-K., & the Korean Society of Neurogastroenterology and Motility
Affiliations: Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Gyeonngi-do, Korea
Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
Department of Internal Medicine, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea
Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Chungcheongnam-do, Korea
Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Chungcheongnam-do, Korea
Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea
Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea
Department of Internal Medicine, Konyang University Hospital, Daejeon, Korea
Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, Korea
Department of Internal Medicine, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea
Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea
Department of Internal Medicine, Yeungnam University Hospital, Daegu, Korea
Department of Internal Medicine and Digestive Disease Research Institute, Wonkwang University School of Medicine, Iksan, Jeonbuk State, Korea
Department of Psychiatry, Wonkwang University Hospital, Iksan, Jeonbuk State, Korea
Division of Healthcare Technology Assessment Research, National Evidence-Based Healthcare Collaborating Agency, Seoul, Korea
Department of Internal Medicine, Kosin University College of Medicine, Busan, Korea
Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea
ORCID: Choi, Yonghoon
Youn, Young Hoon
Kang, Seung Joo
Shin, Jeong Eun
Cho, Young Sin
Jung, Yoon Suk
Shin, Seung Yong
Huh, Cheal Wung
Lee, Yoo Jin
Koo, Hoon Sup
Nam, Kwangwoo
Lee, Hong Sub
Kim, Dong Hyun
Park, Ye Hyun
Kim, Min Cheol
Song, Hyo Yeop
Yoon, Sung-Hoon
Lee, Sang Yeol
Choi, Miyoung
Park, Moo-In
Sung, In-Kyung
Venue: Journal of Neurogastroenterology and Motility
Publisher: The Korean Society of Neurogastroenterology and Motility
Published: 2025-04-30
Volume: 31
Issue: 2
Pages: 133-169
ISSN: 2093-0879
2093-0887
DOI: 10.5056/jnm25007
Cited by: 33
References: 58
Language: en
Licence: creativecommons.org/licenses/by-nc/4.0 (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

2025 Seoul Consensus on Clinical Practice Guidelines for Irritable Bowel Syndrome

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks

Data sources